Latest Shareholder Decision News

Lanthanein Resources is set to raise $2.4 million through a placement and a fully underwritten rights issue, while proposing a strategic name change and share consolidation to streamline its capital structure.

Mayne Pharma has sent out the Scheme Booklet to shareholders, marking a key step in the proposed acquisition by Cosette. The booklet includes critical details to guide shareholder decisions ahead of the upcoming Scheme Meeting.

Emu NL’s recent shareholder meeting saw all attempts to remove or elect new directors decisively rejected, reinforcing board stability as the company completes a planned capital raise.

PointsBet Holdings signals a possible shift in its acquisition path, considering Betr Entertainment's offer as potentially superior to the existing MIXI scheme. The company initiates mutual due diligence focusing on synergies and scrip valuation.

Donaco International reported a modest revenue and EBITDA decline in Q3 FY2025 but strengthened its cash reserves. Meanwhile, the company agreed to a full acquisition scheme at a significant premium, setting the stage for shareholder decisions amid regulatory uncertainties.

Bravura Solutions has received a final Class Ruling from the Australian Taxation Office clarifying the tax treatment of its recent $0.163 per share capital return, providing certainty for shareholders holding shares on capital account.

Vonex Limited has announced a $13.9 million non-renounceable entitlement offer to reduce its substantial debt, with major shareholder Maxo Telecommunications underwriting the raise. The move comes as CEO Ian Porter prepares to depart, marking a pivotal moment for the telecommunications provider.

Xref Limited shareholders convened to vote on SEEK Limited’s proposed $0.218 per share acquisition, representing a substantial premium over recent trading prices. The outcome hinges on shareholder and court approval, marking a pivotal moment for the software company’s future.

Lycaon Resources completes its first drilling program at the Stansmore Nb-REE target, revealing modest mineralization, while reinforcing its leadership with key board appointments and planned capital injections.